Clinical Microbiology is mainly concerned with the prevention, diagnosis, and treatment of infectious diseases. Rising outbreak of epidemics boosts the growth of Microbiology Testing/Clinical Microbiology Market. Microbiology Testing/Clinical Microbiology Market was valued at USD 4.36 billion in 2019 and is projected to reach USD 9.46 billion by 2028, growing at a CAGR of 10.98% from 2019 to 2028. Limited reimbursement policies for microbiology testing methods and the unfavorable regulatory scenario might hamper the overall growth at a global level.

Top Driver: Technological developments in disease diagnostics

Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth. Technological developments in disease diagnostics, growing incidence of infectious diseases, increased public-private investments & funding and rise in outbreaks of epidemics have been driving the global microbiology testing/clinical microbiology market. On the other hand, factors such as limited reimbursement policies for microbiology testing methods and the unfavorable regulatory scenario might hamper the overall growth at a global level.

The instruments segment was the most important contributor to the clinical microbiology market

On the idea of products, the market is categorized into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). The instruments segment is predicted to account for the most important share of the worldwide clinical microbiology market in 2018. Factors like the many adoption of conventional laboratory instruments among end users, technological advancements within the field of molecular techniques & proteomics (such because the integration of microfluidics with PCR and nanotechnology with qPCR techniques), and therefore the ongoing trend of laboratory automation among clinical laboratories, are propelling growth during this segment.

  On the idea of disease area, the clinical microbiology market is segmented into respiratory diseases, bloodstream infections (BSIs), gastrointestinal (GI) diseases, sexually transmitted diseases (STDs), tract infections (UTIs), periodontal diseases, and other diseases (including disorder , central systema nervosum infections, animal tissue & joint diseases, and skin diseases). The respiratory illness segment is estimated to witness the very best growth during the forecast period, primarily thanks to because the large patient population affected by respiratory diseases (coupled with the growing exposure to key risk factors like pollution) and therefore the increasing number of epidemic outbreaks of respiratory infections

Asia Pacific is expected to grow at the highest CAGR in the clinical microbiology market during the forecast period

Asia Pacific is predicted to be the fastest growing region from 2019 to 2028. Japan is one among the leading countries with strong technological developments and high usage of microbial testing for various applications. China is another significant market contributing to regional growth.

Booming medical tourism industry is predicted to spur demand for microbial diagnostic and monitoring tests in Asian countries like India, China, Thailand, and Malaysia. Furthermore, availability of skilled labor at affordable cost and advanced manufacturing infrastructure are leading to manufacturing facilities of major pharmaceutical and medical device makers shifting to Asia. This is often boosting regional market expansion.

North America accounted for the largest revenue share in 2016 and was closely followed by Europe. Highly developed industrial and healthcare sectors in U.S. are fueling adoption of advanced clinical diagnostic techniques. In addition, stringent regulatory framework and presence of leading players are augmenting regional market growth.

Players to Focus on Clinical Microbiology Market

Few of the major competitors currently working in the Clinical Microbiologymarket,

• bioMérieux SA
• Danaher Corporation
• Becton,
• Dickinson Company
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche AG
• Bruker Corporation
• Hologic, Inc.
• QIAGEN N.V
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• 3M Company
• Neogen Corporation

Hologic Inc.; Roche Diagnostics; and Alere Inc. Introduction of automated systems and innovative designs are expected to intensify the competition by changing market dynamics over the forecast period.

Scope of the Report

By Type

• Instruments
• Laboratory Instruments
• Microbiology Analyzers
• Reagents

By Application

• Respiratory Diseases
• Bloodstream Infections
• Gastrointestinal Diseases

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report 

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.